Unknown

Dataset Information

0

Children and adolescents on anti-retroviral therapy in Bulawayo, Zimbabwe: How many are virally suppressed by month six?


ABSTRACT: Background: Zimbabwe is one of the countries in sub-Saharan Africa disproportionately affected by human immunodeficiency virus. In the "treat all" era, we assessed the gaps in routine viral load (VL) monitoring at six months for children (0-9 years) and adolescents (10-19 years) newly initiated on anti-retroviral therapy (ART) from January 2017 to September 2018 at a large tertiary hospital in Bulawayo. Methods: In this cohort study using secondary data, we considered first VL done within six to nine months of starting therapy as 'undergoing VL test at six months'. We classified repeat VL?1000 copies/ml despite enhanced adherence counselling as virally unsuppressed. Results: Of 295 patients initiated on ART, 196 (66%) were children and 99 (34%) adolescents. A total 244 (83%) underwent VL test at six months, with 161 (54%) virally suppressed, 52 (18%) unsuppressed and 82 (28%) with unknown status (due to losses in the cascade). Switch to second line was seen in 35% (18/52). When compared to children, adolescents were less likely to undergo a VL test at six months (73% versus 88%, p=0.002) and more likely to have an unknown VL status (40% versus 22%, p=0.001). Conclusion: At six months of ART, viral suppression was low and losses in the cascade high.

SUBMITTER: Moyo S 

PROVIDER: S-EPMC7194453 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Children and adolescents on anti-retroviral therapy in Bulawayo, Zimbabwe: How many are virally suppressed by month six?

Moyo Silungile S   Ncube Ronald Thulani RT   Shewade Hemant Deepak HD   Ngwenya Solwayo S   Ndebele Wedu W   Takarinda Kudakwashe Collin KC   Dzangare Janet J   Goverwa-Sibanda Tafadzwa Priscilla TP   Apollo Tsitsi T  

F1000Research 20200316


<b>Background:</b> Zimbabwe is one of the countries in sub-Saharan Africa disproportionately affected by human immunodeficiency virus. In the "treat all" era, we assessed the gaps in routine viral load (VL) monitoring at six months for children (0-9 years) and adolescents (10-19 years) newly initiated on anti-retroviral therapy (ART) from January 2017 to September 2018 at a large tertiary hospital in Bulawayo. <b>Methods:</b> In this cohort study using secondary data, we considered first VL done  ...[more]

Similar Datasets

| S-EPMC6990521 | biostudies-literature
| S-EPMC7859627 | biostudies-literature
| S-EPMC9216256 | biostudies-literature
| S-EPMC5496338 | biostudies-other
| S-EPMC6925874 | biostudies-literature
| S-EPMC7064124 | biostudies-literature
| S-EPMC8655986 | biostudies-literature
| S-EPMC7928382 | biostudies-literature
| S-EPMC8326552 | biostudies-literature
| S-EPMC5131686 | biostudies-literature